Search reports.
Womens Health Market Size, Industry Trends Report | 2031
Get free sample report Request for Customiztion Buy Now

Womens Health Market Size, Industry Trends Report | 2031

Segments - Womens Health Market by Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-717 | 4.1 Rating | 65 Reviews | 135 Pages | Format : PDF Excel PPT

Report Description


Womens Health Market Outlook 2031

The global women’s health market size was valued at USD 36.94 Billion in 2022 and is likely to reach USD 56.82 Billion by 2031, expanding at a CAGR of 4.9 % during the forecast period, 2023–2031. The growth of the market is attributed to the increasing geriatric women population, increasing lifestyle disorders, development of innovative medicines for women.

Menstrual cycles, pregnancy, birth control, and menopause are just a few of the health issues that women face. A number of health problems are unique to women, while others are more prevalent in women. Furthermore, males and women may have the same disease yet exhibit it different symptoms. Many diseases affect women differently and may need therapy that is tailored to their needs.

Womens Health Market Market Outlook

Women’s health consists of treatments, drugs and surgical products for various diseases which affect women. Nutrition, cancer, reproduction, menopause, urology, and other medical applications are among these disorders. Women's health attempts to improve disease management and general health in women. Many governments are stepping up their efforts to raise awareness about women's health.

Some institutions, such as the Food and Drug Administration (FDA) in the United States and the World Health Organization (WHO), are taking measures to develop new safety initiatives to enhance women's health. The FDA's primary aim, for example, is to improve the health of women across the world. Organizations are progressively focusing on enhancing security measures, recognizing security concerns, and boosting patient understanding to achieve these goals.

The FDA has authorized numerous laser and energy devices for the treatment of a number of ailments, including the elimination of precancerous tissues of the cervix or vaginal region, as part of this approach. These initiatives increase awareness of women's health risks and stimulate the use of women's health services, resulting in increased growth in the worldwide women's health market.

Women's fatality rates from breast cancer, cardiovascular disease, and cervical cancer have all decreased significantly in recent years. This is due to increased consumer demand and awareness, which has resulted in more investment and research, as well as improved diagnosis, screening, and treatment.

  • Increasing efforts by governments to spread awareness and favorable initiatives by governments to improve women’s health is projected to drive the market growth during the forecast period.
  • Increasing incidence of diseases like osteoporosis, osteoarthritis, anemia, menstrual health-related disorders, depression, obesity, breast cancer, cardiovascular diseases, and mental diseases amongst women are anticipated to drive the market growth in the coming years.
  • Side effects associated with some women intensive surgeries and drugs are projected to hamper the market growth in the coming years.
  • High cost of some treatments is expected to restrict the market growth in the forecasted period.
  • Increased emphasis on R&D for development of novel drugs, treatments, methods for diagnosis of various disorders are projected to offer lucrative opportunities for the market players.

Scope of Womens Health Market Report

The report on the global women’s health market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Women’s Health Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Application (Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V.

Womens Health Market Segment Insights

Postmenopausal osteoporosis segment is expected to account for a key share of the market

Based on application, the women’s health market is segmented into postmenopausal osteoporosis, hormonal infertility, endometriosis, contraceptives, menopause, polycystic ovary syndrome. The postmenopausal osteoporosis segment is expected to account for a key share of the market during the forecast period due to increasing population of women above 40 years and increasing number of product development cure menopausal osteoporosis and improve health.

On the other hand, the hormonal infertility segment is anticipated to expand at a rapid pace during the forecast period owing to increased fertility related issues in developed countries. Furthermore, the segment will grow due to the easy availability of several drugs to treat hormonal imbalances and market players' efforts in new product development throughout the forecast period.

Hormonal imbalances, such as prolactin, estrogen, and thyroid imbalances, are becoming more common in women as a result of causes such as stress, fueling demand for medicine to restore health.

Womens Health Market Application

Womens Health Market Regional Outlook

North America is anticipated to dominate the market

On the basis of regions, the women’s health market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at an impressive CAGR during the forecast period.

The regional market growth can be attributed to the presence of key market players, favorable reimbursement policies, favorable legislation, product approval and commercialization, and increased awareness of the value of good health.

The market is also fueled by an increase in the number of FDA-approved menopause medicines, increasing healthcare expenditure, and women's preference for biologics.

On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to growing awareness of women's well-being and health, as well as an increase in the prevalence of osteoarthritis, infertility, and other stress-related problems, as well as numerous government initiatives aimed at raising women's health diagnostics and awareness.

Womens Health Market Region

Segments

Application

  • Postmenopausal Osteoporosis
  • Hormonal Infertility
  • Endometriosis
  • Contraceptives
  • Menopause
  • Polycystic Ovary Syndrome (PCOS)

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Allergan
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer
  • Teva Pharmaceuticals
  • Agile Therapeutics
  • Amgen, Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • Ferring B.V.

Competitive Landscape

Key players competing in the women’s health market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb; and Ferring B.V.

Some of the key business strategies adopted by the key companies includes mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares. For instance,

For example, in September 2020, Health & Her, a female wellness company located in Cardiff, launched an app to assist women manage their menopausal journey, which includes workout recommendations, period monitoring, and symptom evaluation. Health & Her Perimenopause and Menopause Food Supplements is a new supplement line created by the firm.

Womens Health Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Women’s Health Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Women’s Health Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Women’s Health Market - Supply Chain
  4.5. Global Women’s Health Market Forecast
     4.5.1. Women’s Health Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Women’s Health Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Women’s Health Market Absolute $ Opportunity
5. Global Women’s Health Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Women’s Health Market Size and Volume Forecast by Applications
     5.3.1. Postmenopausal Osteoporosis
     5.3.2. Hormonal Infertility
     5.3.3. Endometriosis
     5.3.4. Contraceptives
     5.3.5. Menopause
     5.3.6. Polycystic Ovary Syndrome (PCOS)
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Women’s Health Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Women’s Health Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Women’s Health Demand Share Forecast, 2019-2026
7. North America Women’s Health Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Women’s Health Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Women’s Health Market Size and Volume Forecast by Applications
     7.4.1. Postmenopausal Osteoporosis
     7.4.2. Hormonal Infertility
     7.4.3. Endometriosis
     7.4.4. Contraceptives
     7.4.5. Menopause
     7.4.6. Polycystic Ovary Syndrome (PCOS)
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Women’s Health Demand Share Forecast, 2019-2026
8. Latin America Women’s Health Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Women’s Health Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Women’s Health Market Size and Volume Forecast by Applications
     8.4.1. Postmenopausal Osteoporosis
     8.4.2. Hormonal Infertility
     8.4.3. Endometriosis
     8.4.4. Contraceptives
     8.4.5. Menopause
     8.4.6. Polycystic Ovary Syndrome (PCOS)
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Women’s Health Demand Share Forecast, 2019-2026
9. Europe Women’s Health Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Women’s Health Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Women’s Health Market Size and Volume Forecast by Applications
     9.4.1. Postmenopausal Osteoporosis
     9.4.2. Hormonal Infertility
     9.4.3. Endometriosis
     9.4.4. Contraceptives
     9.4.5. Menopause
     9.4.6. Polycystic Ovary Syndrome (PCOS)
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Women’s Health Demand Share Forecast, 2019-2026
10. Asia Pacific Women’s Health Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Women’s Health Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Women’s Health Market Size and Volume Forecast by Applications
     10.4.1. Postmenopausal Osteoporosis
     10.4.2. Hormonal Infertility
     10.4.3. Endometriosis
     10.4.4. Contraceptives
     10.4.5. Menopause
     10.4.6. Polycystic Ovary Syndrome (PCOS)
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Women’s Health Demand Share Forecast, 2019-2026
11. Middle East & Africa Women’s Health Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Women’s Health Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Women’s Health Market Size and Volume Forecast by Applications
     11.4.1. Postmenopausal Osteoporosis
     11.4.2. Hormonal Infertility
     11.4.3. Endometriosis
     11.4.4. Contraceptives
     11.4.5. Menopause
     11.4.6. Polycystic Ovary Syndrome (PCOS)
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Women’s Health Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Women’s Health Market: Market Share Analysis
  12.2. Women’s Health Distributors and Customers
  12.3. Women’s Health Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Allergan
     12.4.2. Bayer AG
     12.4.3. Merck & Co., Inc.
     12.4.4. Pfizer
     12.4.5. Teva Pharmaceuticals
     12.4.6. Agile Therapeutics
     12.4.7. Amgen, Inc.
     12.4.8. AstraZeneca

Methodology

Our Clients

General Electric
Deloitte
sinopec
The John Holland Group
Microsoft
Siemens Healthcare
Dassault Aviation
Nestle SA